Publications by authors named "Yu Amemiya"
The 2024 revised edition of the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock (J-SSCG 2024) is published by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine. This is the fourth revision since the first edition was published in 2012. The purpose of the guidelines is to assist healthcare providers in making appropriate decisions in the treatment of sepsis and septic shock, leading to improved patient outcomes.
View Article and Find Full Text PDFThe 2024 revised edition of the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock (J-SSCG 2024) is published by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine. This is the fourth revision since the first edition was published in 2012. The purpose of the guidelines is to assist healthcare providers in making appropriate decisions in the treatment of sepsis and septic shock, leading to improved patient outcomes.
View Article and Find Full Text PDFBackground: Tranexamic acid (TXA) has been used to treat traumatic brain injury (TBI); however, no definitive conclusions have been drawn regarding its effectiveness or dosage. This study evaluated the optimal TXA dose for treating TBI using a network meta-analysis (NMA).
Methods: Five databases were searched for peer-reviewed randomized controlled trials (RCTs) published from inception to May 2024.
Article Synopsis
- The study examined chest CT findings in patients with severe acute respiratory distress syndrome (ARDS) undergoing veno-venous extracorporeal membrane oxygenation (V-V ECMO) across 24 hospitals in Japan.
- Among 582 patients who had chest CT at V-V ECMO initiation, traction bronchiectasis and subcutaneous emphysema were associated with increased 90-day mortality, while patients with traction bronchiectasis were less likely to be successfully liberated from ECMO.
- The findings suggest that certain chest CT features can provide important prognostic information and may be useful for predicting outcomes in severe ARDS patients on V-V ECMO.
The benefits of introducing a systematic lung-protective protocol for coronavirus disease 2019 (COVID-19) pneumonia requiring invasive ventilation in the intensive care unit (ICU) are unknown. Herein, we aimed to evaluate the clinical effects of introducing such a protocol in terms of mortality, duration of ventilation, and length of ICU stay. In this single-centre, retrospective, quality comparison study, we identified patients with COVID-19 pneumonia who received invasive ventilation in our ICU between February 2020 and October 2021.
View Article and Find Full Text PDF